762 related articles for article (PubMed ID: 10392260)
1. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
3. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[TBL] [Abstract][Full Text] [Related]
4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
5. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
Ibels LS; Györy AZ
Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
[TBL] [Abstract][Full Text] [Related]
6. [IgA nephropathy in patients above 45 years of age. Clinical and morphologic analysis].
Wagrowska-Danilewicz M; Danilewicz M; Szemraj M
Pol Merkur Lekarski; 1997 Sep; 3(15):115-8. PubMed ID: 9461706
[TBL] [Abstract][Full Text] [Related]
7. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
8. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
9. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
[TBL] [Abstract][Full Text] [Related]
10. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
11. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
[TBL] [Abstract][Full Text] [Related]
12. Vascular diseases and their risk factors in IgA nephropathy.
Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
[TBL] [Abstract][Full Text] [Related]
13. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
[TBL] [Abstract][Full Text] [Related]
14. Natural history of primary IgA nephropathy.
Berthoux FC; Mohey H; Afiani A
Semin Nephrol; 2008 Jan; 28(1):4-9. PubMed ID: 18222341
[TBL] [Abstract][Full Text] [Related]
15. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
Frimat L; Hestin D; Aymard B; Mayeux D; Renoult E; Kessler M
Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
[TBL] [Abstract][Full Text] [Related]
16. [First case of primary IgA glomerulonephritis (Berger's disease) in Senegal].
Diouf B; Diao M; Niang A; Ka EF; Moreira Diop T
Dakar Med; 1999; 44(1):140-2. PubMed ID: 10798006
[TBL] [Abstract][Full Text] [Related]
17. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients.
D'Amico G; Imbasciati E; Barbiano Di Belgioioso G; Bertoli S; Fogazzi G; Ferrario F; Fellin G; Ragni A; Colasanti G; Minetti L
Medicine (Baltimore); 1985 Jan; 64(1):49-60. PubMed ID: 3880853
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
20. Thin basement membrane disease in patients with familial IgA nephropathy.
Frascá GM; Soverini L; Gharavi AG; Lifton RP; Canova C; Preda P; Vangelista A; Stefoni S
J Nephrol; 2004; 17(6):778-85. PubMed ID: 15593051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
